Introduction
History
Types of immunity
Tissues of immunity
Cells of immunity
Basic aspects of immunology
Major histocompatibility complex
Cytokines
Disorders of immune system
Immune responses in periodontal pathogenesis
Periodontal vaccine
Host modulation
Conclusion
References
Introduction
History
Types of immunity
Tissues of immunity
Cells of immunity
Basic aspects of immunology
Major histocompatibility complex
Cytokines
Disorders of immune system
Immune responses in periodontal pathogenesis
Periodontal vaccine
Host modulation
Conclusion
References
Drug absorption by the human intestine
Models of intestinal absorption of pharmaceutical compounds.
Characteristics of Caco-2 cells
Permeability assessment
Cultivation of Caco-2 cell monolayers
Trans Epithelial Electrical Resistance (TEER) measurement
LY rejection
Caco-2 permeability assay procedure
Apparent permeability, Papp(cm/s) & Efflux Ratio
1. Introduction
2. Phases of metabolism
3. Phase-I Metabolism
4. Cytochrome P family
5. Phase –II Metabolism
6. First pass metabolism
7. Ante Drugs
8. Microsomal Enzymes induction
Role of metabolism in drug discovery
1. INTRODUCTION TO CELL CULTURE
2. SOURCES & TYPES OF CONTAMINATION
3. MONITORING OF CONTAMINATION IN CELL CULTURE
4. CROSS CONTAMINATION
5. ANTIBIOTIC USE
1. History of Cell Culture
2. Introduction to cell culture
3. types of cell lines
4. culture media
5. serum in culture media
6. Applications of cell & tissue culture
7. Adherence
8. Cell line evolution
9. Passaging, revival and cryopreservation
10. cell culture laboratory layout
Introduction to cell culture- concepts of cell culture part-1PHARMA IQ EDUCATION
Introduction to Cell Culture
What is Cell Culture?
Finite vs Continuous Cell Line
Culture Conditions
Cryopreservation
Morphology of Cells in Culture
Applications of Cell Culture
This document contains the mostly asked questions for the job interviews of drug regulatory affairs which will help the candidate ace the interview with ease
Thank me later for this :*)
1. What are hypersensitivity reactions
2. Types of hypersensitivity reactions
3. Type 1 Hypersensitivity reaction
4. Type 2 Hypersensitivity reaction
5. Type 3 Hypersensitivity reaction
6. Type 4 Hypersensitivity reaction
7. Summary
1. Introduction & Pathophysiology of Liver fibrosis
2. Experimental Models of Hepatic fibrosis
3. Timeline of development of Fibrotic models
4. Surgically developed models for Fibrosis
5. Chemically Induced Models for Fibrosis
6. Diet Induced Models for Fibrosis
7. Infection based models
8. Extra points
9. Conclusion
10. References
1. WHAT IS HEPATIC CIRRHOSIS
2. STAGES OF HEPATIC CIRRHOSIS
3. HEPATIC CIRRHOSIS ASSOCIATED COMORBIDITIES
4. PATHOPHYSIOLOGY OF HEPATIC CIRRHOSIS
5. MOLECULAR AND CELLULAR MECHANISMS INVOLVED IN LIVER FIBROGENESIS
6. FREE RADICALS
7. HOW DO FREE RADICALS CAUSE HEPATIC FIBROSIS/ CIRRHOSIS
8. POTENTIAL THERAPEUTIC COMPOUNDS BASED ON ANTIOXIDANT PROPERTIES
1. WHAT IS GENE THERAPY
2. PRINCIPLE OF GENE THERAPY
3. TYPES OF GENE THERAPY
4. VECTORS IN GENE DELIVERY SYSTEM
5. ROLE OF GENE THERAPY IN CNS DISORDERS
6. GENE THERAPY FOR ALZHEIMERS DISEASE
7. GENE THERAPY FOR AMYOTROPIC LATERAL SCLEROSIS
8. GENE THERAPY FOR STROKE
9. CELL THERAPY FOR CNS DISORDERS
10. CELL THERAPY STRATEGIES
11. CELL THERAPY FOR PARKINSON
12. CELL THERAPY FOR HUNTINGTONS DISEASE
13. CRISPR/CAS9
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Immunopharmacology & immunology Unit-1 (PC-660)
1. Introduction to immunopharmacology,
immunomodulators, immunostimulants and
Immunosuppressants
UNIT-1 Chemotherapy and Immunopharmacology (PC- 660)
2 Credits
Priyansha Singh
B. Pharm, M.S. (Pharm.)- Pharmacology & Toxicology
2. Immunopharmacology is the study of the
effects of the drugs modifying immune
mechanism in body.
It is the ability of the living body or the process to fight various
types of microorganisms, toxins or tumour cells that tend to damage
the tissue and organs.
Immune mechanism ?
4. • Immunology
• Study of the components and function of the immune system
• Immune System
• Molecules, cells, tissues and organs which provide non-specific and
specific protection against
• Microorganisms
• Microbial toxins
• Tumor cells
• Crucial to human survival
Specificity
Recognition of self
Memory
Salient features
5. Immunity
• First line of defense
• Anatomic barriers (Skin, mucous
membranes)
• Physiological barriers (temperature,
pH)
• Phagocytic Barriers (cells that eat
invaders)
• Inflammatory barriers (redness,
swelling, heat and pain)
• Second line of defense
• Antigen specificity
• Diversity
• Immunological memory
• Self/non-self recognition
Innate (non-specific) immunity Adaptive (specific) immunity
Components of immune system
• Humoral immunity - Antibody
production – killing extracellular
organisms.
• Cell mediated immunity –
cytotoxic / killer T cells – killing
virus and tumour cells.
7. Origin of cells of the immune system
Derived from common progenitor
cell in bone marrow
Pluripotent hematopoietic
stem cell
Progenitor Stem Cells
Erythroid lineage
Erythrocytes and
Megakaryocytes
Myeloid lineage
Monocyte/macrophage,
dendritic cells, PMN’s,
mast cells
Lymphoid lineage
Small and large
lymphocytes
8. Cells of innate and adaptive immunity
Myeloid Lineage
•Neutrophil
• Principal phagocytic cell of innate immunity
•Eosinophil
• Principal defender against parasites
•Basophil
• Functions similar to eosinophils and mast cells
• Referred to as
• Polymorphonuclear leukocytes (PMN’s)
• Nuclei are multilobed (2 to 5)
• Granulocytes
• Cytoplasmic granules
9. • Monocytes
• Leukocytes with bean-shaped or
brain-like convoluted nuclei
• Circulate in blood with half life of 8
hours
• Precursors of tissue macrophages
• Macrophages
• Mononuclear phagocytic cells in
tissue
• Derive from blood monocytes
• Participate in innate and adaptive
immunity
Cells of innate and adaptive immunity
Myeloid Lineage
10. •Dendritic cells
• Cells with dendriform (star shaped)
morphology
• Interdigitating reticular cells
(synonym)
• Capture and present antigens to T
lymphocytes
•Mast cells
• Located in mucous membrane and
connective tissue throughout body
• Major effector cell in allergy
• Modulation of initial immune
response
Cells of innate and adaptive immunity
Myeloid Lineage
11. •Large lymphocytes (large granular lymphocytes)
• Natural killer (NK) cells (CD16, CD56)
• Innate immunity to viruses and other intracellular pathogens
• Participate in antibody-dependent cell-mediated cytotoxicity (ADCC)
•Small lymphocytes
• B cells (CD19)
• T cells (CD3, CD4 or CD8)
• Adaptive immunity
Cells of innate and adaptive immunity
Lymphoid Lineage
12. Lymphocytes originate in bone marrow
Lymphoid tissues and organs
• Primary
• Development and maturation of lymphocytes
• Bone Marrow (B cells) and thymus gland (T cells)
• Secondary
• Mature lymphocytes meet pathogens
• Spleen, adenoids, tonsils, appendix, lymph nodes, Peyer’s patches,
mucosa-associated lymphoid tissue (MALT)
Lymphocytes, lymphoid tissues and organs
13. Secondary lymphoid tissues associated
with mucous membranes
Primary portals of entry for pathogens
• Respiratory tract
• Gastrointestinal tract
Secondary lymphoid tissues
• Bronchial-associated lymphoid
tissue (BALT)
• Gut-associated lymphoid tissues
(GALT)
Tonsils, adenoids, appendix,
Peyer’s patches
Pathogens are directly transferred
across mucosa by “M” cells
14. The innate immune response
• Mediated (initiated) by
phagocytes, NK cells and
soluble proteins
• Phagocytes
• Cells specialized in the
process of phagocytosis
• Macrophages
• Reside in tissues and
recruit neutrophils
• Neutrophils
• Enter infected tissues
in large numbers
• Recognize common
molecules of bacterial cell
surface using a few surface
receptors
• Phagocytosis
• Capture, engulfment and
breakdown of bacterial
pathogen
15. • Inflammatory response enhances phagocytosis through acute phase proteins
• Mannose-binding lectin (MBL)
• Binds to bacterial surface with particular spatial arrangement of mannose or fucose
• C-reactive protein (CRP)
• Binds to phosphorylcholine on bacterial surface
• Complement
• Set of proteins which bind to bacterial surface
• Inflammatory response
• Accumulation of fluid and cells at infection site (swelling, redness, heat and pain)
The innate immune response
16. Naturally acquired immunity
Active
• Antigens enter body naturally with response of
Innate and adaptive immune systems
• Provides long term protection
Passive
• Antibodies pass from mother to
Fetus across placenta
Infant in breast milk
• Provides immediate short term protection
17. Active
•Antigens enter body through vaccination with response of
Innate and adaptive immune systems
•Provides long term protection
Passive
•Antibodies from immune individuals injected into body
•Referred to as
Immune serum globulins (ISG)
Immune globulins (IG)
Gamma globulins
•Provides immediate short-term protection
Artificially acquired immunity
18. The adaptive immune response
• Creates millions of different B and T cells for specific antibody-mediated and cell-
mediated immunity
• Antibody-Mediated Immunity (AMI)
• Involves B lymphocytes, plasma cells and antibodies
• Humoral immunity
• Name derives from antibodies found in body fluids (humors - old medical term)
• Cell-Mediated Immunity (CMI)
• Involves T lymphocytes, antigen-presenting cells and MHC (major
histocompatibility complex) molecules
• Cellular immunity
19. Antigens?
A substance that when introduced into the body, stimulates
the production of an antibody.
An antigen is an organic compound - protein,
polysaccharide or glycolipid.
Antigens include:
Toxins
Bacteria
Foreign blood cells
Microorganisms
Allergens
20. Antibody?
They are gamma globulins or immunoglobulin's
produced in the serum on exposure to antigen.
Chemically they are glycoprotein's containing two
heavy chains and two light chains joined together by
disulfide bonds.
It has 2 parts
Fab
Fc
There are 5 types of Antibodies: IgG ,IgM , IgA , IgE , IgD
21. Immunopharmacology is the study of the effects of
the drugs modifying immune mechanism in body.
Hypersensitivity disorders or allergies
Autoimmunity or autoimmune disorders
Primary or secondary immunodeficiencies:
These disorders are characterized by immune system not capable of
mounting a normal immune response
Immunoproliferative disorders:
Malignancies of the immune system (multiple myeloma,
lymphoma, leukemia, etc)
What happens to the immune system?
22. Allergy is one of the consequences of immunological response involving antigen-antibody
reaction.
It is the increased reactivity to foreign antigen by the normal immune system. Hence, it is
also called hypersensitivity.
Two French scientists, Paul Portier and Charles Richet, were the first to recognize and
describe hypersensitivities.
There are multiple types of hypersensitivity reactions.
Immediate hypersensitivity reactions result in symptoms that manifest themselves
within very short time periods after the immune stimulus.
Other types of hypersensitivity reactions take hours or days to manifest themselves, and
are referred to as delayed- type hypersensitivity (DTH) reactions.
Hypersensitivity disorders or allergies
Immediate hypersensitivity reactions result from antibody-antigen
reactions, whereas DTH is caused by T-cell reactions.
23. Hypersensitivity disorders or allergies
P. G. H. Gell and R. R. A. Coombs, proposed a classification scheme to
discriminate among the various types of hypersensitivity.
1-Type I - Immediate
(atopic, or anaphylactic)
2-Type II – Cytotoxic
hypersensitivity
3-Type III - Immune complex
hypersensitivity
4-Type IV – Cell-mediated or
Delayed type hypersensitivity
24. Hypersensitivity disorders or allergies
Type I hypersensitivity reactions are mediated by IgE antibodies and
include many of the most common allergies to respiratory allergens, such
as pollen and dust mites.
Type II hypersensitivity reactions result from the binding of IgG or IgM
to the surface of host cells, which are then destroyed by complement- or
cell-mediated mechanisms.
In type III hypersensitivity reactions, antigen-antibody complexes
deposited on host cells induce complement fixation and an ensuing
inflammatory response.
Type lV hypersensitivity reactions result from inappropriate T-cell
activation.
Humoral
Cell
mediated
25. Type Immune mechanism Typical example
I. Anaphylactic type. Allergen(Ag) cross-links Ab release of vasoactive
amines and other mediators from basophils and
mast cells recruitment of other inflammatory cells.
Anaphylaxis, some forms of bronchial
asthma.
II. Antibody to fixed
tissue antigen.
IgG or IgM binds to Ag on cell surface phagocytosis
of target cell or lysis of target cell by complement
or Ab dependent cell-mediated cytotoxicity(ADCC).
Autoimmune haemolytic anaemia,
transfusion reactions, hemolytic
disease of the newborn
(erythroblastosis foetalis in humans).
III. Immune complex
disease.
Ag-Ab complexes activate complement attract
neutrophils release of lysosomal enzymes, oxygen
free radicals, etc.
Arthus reaction, serum sickness,
certain forms of acute
glomerulonephritis.
IV. Cell-mediated
(delayed)
hypersensitivity.
Sensitized T-lymphocyte release of cytokines and
T-cell-mediated cytotoxicity.
Tuberculin reaction, TB, contact
dermatitis, transplant rejection.
Hypersensitivity disorders or allergies
26. Auto-immune disorders occur when the immune system can not distinguish between self
antigen and foreign antigen and reacts against self-antigen.
Auto-immune disorders
By activation of self reactive T & B lymphocytes that produce cell-mediated response
directly against self-antigen and lead to killing of body’s own cells.
Eg. Rheumatoid arthritis
Myasthenia gravis
Ulcerative anemia etc
It may be organ specific – autoimmune response directed against particular disease like
thyroid in Hashimoto.s thyroiditis, or nonorgan-specific – against widespread antigens
such as cell nuclear antigens in Lupus.
Mechanism:
The development of autoimmune disease
depends on a combination of genetic and
environmental factors like hormones,
diet, toxins, drugs and infections.
27. Immunosuppressants
Therapies in immunopharmacology
Immunostimulants or Immunoenhancers
Immunomodulators
Natural or synthetic substances
that help regulate or
normalize the immune system
They correct immune systems
out of balance, i.e., strengthen
weak immune systems or
moderate over reactive immune
systems.
Agents that are envisaged to enhance
body’s resistance against infections
They enhance the basal levels of immune
response, especially in
immunodeficiency
Agents that suppress the immune system
Used for the control of pathological immune
response in autoimmune disease or
hypersensitivity
28.
29. Specific immunostimulants
Immunostimulants
Non-specific immunostimulants
Provide antigenic specificity in
immune response, such as vaccines
or any antigen.
They act irrespective of antigenic
specificity to augment immune
response of other antigen or stimulate
components of the immune system
without antigenic specificity, such as
adjuvants
Immunostimulants or Immunoenhancers
30. Immunostimulants or Immunoenhancers
The agents are:
Cytokines
• Immunoregulatory proteins synthesized within lymphoreticular cells
• Cytokines mediate their effects through receptors on relevant target cells
• They have antiproliferative, antimicrobial, & antitumor effects.
• Most cytokines (TNFα, IFN-ɣ, IL2, granulocyte colony-stimulating factor "G- CSF", &
granulocyte-macrophage colony-stimulating factor "GM-CSF"), have very short serum
t1/2 (minutes).
Interferons (INFs):
Type II IFN, acid-labile protein, includes IFN-ɣ that acts on a separate receptor on target cells
& usually it is product of activated T- lymphocytes.
Proteins having antiviral, immunomodulatory, & antiproliferative activities.
.
Type I IFNs,
acid-stable proteins, include IFN-α & IFN-β that act on the same receptor on target cells &
usually induced by viral infections, with leukocytes producing IFN-α while fibroblasts &
epithelial cells produce IFN-β.
31. Immunostimulants or Immunoenhancers
IFNs:
↑expression of MHC molecules on cell surfaces; where all three types of IFNs induce
MHC class I molecules, only IFN-ɣ induces class II expression.
In glial cells, IFN-β antagonizes this effect & may ↓antigen presentation within the
nervous system.
IFN-ɣ: display immune-enhancing properties include ↑antigen presentation & macrophage,
NK cell, & cytotoxic T-lymphocyte activation
IFN-α & IFN-β (more potent than IFN-ɣ), inhibit cell proliferation.
Interferons (INFs):
Cytokines
Mechanisms of actions
IFN-α approved for several neoplasms include, hairy cell leukemia, chronic myelogenous leukemia,
malignant melanoma, & Kaposi's sarcoma. Also for hepatitis B & C infections, & shown anticancer
activity in renal cell carcinoma, carcinoid syndrome, & T- cell leukemia.
IFN-β approved for relapsing-type multiple sclerosis.
IFN-ɣ approved for treatment of chronic granulomatous disease.
Uses:
32. Immunostimulants or Immunoenhancers
Cytokines
T-cell growth factor or IL2
MOA:
Binds to IL2 receptor on surface of responsive cell inducing proliferation of T- cytotoxic cell
& B –cell
Stimulate macrophage activity, & increase toxicity of NK –cells.
Uses:
Used for metastatic melanoma & renal cell carcinoma
Colony stimulating factors - Granulocyte-macrophage colony-stimulating factor
"GM-CSF"
Recombinant Cytokines
Recombinant IL2, which promotes
production of cytotoxic T –cells &
activates NK –cells.
Used in renal cell carcinoma &
lymphoma.
Recombinant IL1 receptor antagonist that
prevents IL1 from binding to its receptor,
stemming the cascade of cytokines released if IL1
were to bind to the IL1-Rc.
Approved for RA in adult pt who have failed
treatment with DMARDs (disease- modifying anti-
rheumatic drugs).
Aldesleukin
Used to rescue BM graft failure & to help graft recovery after autologous BM transplant.
In prophylaxis of cancer chemotherapy induced neutropenia.
Anakinra
33. Immunostimulants or Immunoenhancers
Bacillus Calmette-Guerin (BCG) vaccine
• Available as attenuated strain of Mycobacterium bovis , the active
component is muramyl dipeptide.
• It is not only used for tuberculosis but also in leukaemia
• Stimulates macrophages and this macrophages produce cytotoxicity
against neoplastic cells and also increase phagocytic activity
Lipopolysaccharides:
• This agents increase antibody production and produce the characteristic
biological activities of endotoxin from gram-positive bacteria
Anthelminthes: Levamisole
• It increases the breakdown of c-AMP and decreases the breakdown of c-
GMP so produce the cytotoxicity and phagocytosis
Thalidomide
Isoprinosine
Immunocynin
34. Immunophilin ligands: (selective inhibitors of
cytokine production & function)
e.g. Cyclosporine, Tacrolimus, & Sirolimus
Cytotoxic agents: (immunosuppressant
antimetabolites & alkylating agents)
e.g. Methotrexate "MTX", Azathioprine "AZT",
Mycophenolate mofetil, Leflunomide, Cyclophosphamide.
Also others like hydroxychloroquine, Cytarabine,
Pentostatin, Vincristine, & Vinblastine
Corticosteroids:
e.g. Prednisone & its derivatives
Immunosuppressive antibodies:
• Immunoglubin based:
e.g. Anti-lymphocyte & anti-thymocyte antibodies
• Immunosuppressive mAbs:
e.g. anti-TNFα (adalimumab, etanrecept, infliximab),
IL2-Rc antagonists (daclizumab, basiliximab), IL6-Rc
antagonist (tocilizumab "atlizumab"), & CD-
antagonists (alefacept, muromonab, efalizumab,
abatacept)
Immunosuppressants
MOA: Inhibit antigen stimulated activation and
proliferation of a helper T cells as well as expression
of IL-2 and other cytokines by them.
MOA: Cytotoxic drugs block proliferation and
differentiation of T and B cells.
MOA: Inhibit MHC expression and IL-I. IL –II. IL-6
production so that Helper T cells are not activated.
MOA: They specifically bind to helper T cells and
prevent their response and deplete them.
35. Organ transplantation (suppress rejection of transplanted
organ or tissue)
e.g. kidney, heart, liver, & bone marrow
Autoimmune diseases
e.g. Idiopathic thrombocytopenic purpura, autoimmune
hemolytic anemia, acute glomerulonephritis, hemolytic
disease of newborn (erythroblastosis fetalis), & RA
Prevention of cell proliferation
e.g. Coronary stents
Immunosuppressants
Clinical uses of immunosuppressive agents:
36. COVID-19 – The actual fate
Viral infection &
replication
Host inflammatory response
Cytokine storm
Viral evasion of cellular immune responses
SARS-CoV-2
infection
What we know?
What we do not know?
What we should know?
How to predict Covid progression & severity?
Systemic pro- inflammatory cytokines – IL-6 (<7.0 pg/ml)
Biomarkers – Ferritin (13-150 ng/ml)
Degree of D-dimer causes venous thromboembolism (<0.50
mg/ml FEU)
C-reactive protein (CRP) (<0.50 mg/dL)
Lactate dehydrogenase (LDH) (135-214 U/L)
Chance
Of
survival?
Rapid deterioration & worsening respiratory
symptoms requiring hospital admission
predictors
37. Anti-cytokines: Interleukin (IL)-1
IL-6 receptor antagonists (e.g. anakinra, tocilizumab, sarilumab,
siltuximab)
Janus kinase (JAK) inhibitors (e.g. baricitinib, ruxolitinib)
Anti-tumor necrosis factor-α (e.g. adalimumab, infliximab)
Granulocyte-macrophage colony-stimulating factors (e.g. gimsilumab,
lenzilumab, namilumab)
Human immunoglobulin
Corticosteroids (e.g. dexamethasone)
Interferons
Statins
Angiotensin pathway modulators, macrolides (e.g. azithromycin, clarithromycin)
Hydroxychloroquine and chloroquine, Colchicine
Prostaglandin D2 modulators (e.g. ramatroban)
Non-specific immune modulators
Specific immune modulators
To treat the cytokine storm and inhibit cytokines – immunomodulators are used.
COVID-19 – The actual fate
Management and treatment of Covid is still a research with promising to negative
trials or recovery trials.
Not routinely
recommended
38. Uncontrolled diabetes
mellitus
Immunosuppression
by steroids
Prolonged ICU stay
Co-morbidities – post
transplant/malignancy
Covid-19 and Mucormycosis
What predisposes the Covid-19 patients to the deadly black fungal infection?
39. Utilizes body’s own immune
system to fight disease
Drugs act on immune system so
they don’t harm any other organ or
cellular tissue
Less potential treatment but has
very less side effects
It prolongs the life span
Kills Cancer cells directly
Damages surrounding tissues
More potential treatment but has
more side effects
Quicker results as compared to
immunotherapy
Therapeutic Advances
Immunotherapy vs Chemotherapy
Immunotherapy
Chemotherapy
40. Recent technologies
For melanoma
T cells are removed from a
patient, genetically modified
or treated with chemicals to
enhance their activity or
numbers, and then re-
introduced into the patient
with the goal of improving the
immune system’s anti-cancer
response.
Designed to elicit an immune
response against tumor-
specific or tumor-associated
antigens, encouraging the
immune system to attack
cancer cells bearing these
antigens.
For melanoma
Combination of Hyper
Acute-Melanoma vaccine
(dorgenmeltucel-L) and
ipilimumab in patients
Adoptive T Cell Therapy Therapeutic cancer vaccines Checkpoint inhibitors